Group 1 - Beikang Medical-B (02170) saw a nearly 6% increase in stock price, currently trading at 3.91 HKD with a transaction volume of 4.3854 million HKD [1] - The company announced that its Gems culture medium (embryo handling medium VitBase) has officially received registration certification from the National Medical Products Administration (NMPA), marking a milestone in China's assisted reproduction field [1] - This certification signifies that domestic high-end culture media have entered the international leading ranks, breaking the monopoly of imported brands that has lasted for over 30 years [1] Group 2 - VitBase is part of Beikang's international brand BMX and is a star product in the GEMS series, which has been favored by Chinese embryologists for 30 years [1] - Currently, 11 products have received EU CE certification, 8 products have been approved by the US FDA, and 11 products meet Australian TGA standards, covering the entire process of assisted reproduction [1]
港股异动 | 贝康医疗-B(02170)尾盘涨近6% Gems培养液获得注册证 推动辅助生殖用液国产化